Skip to main content
Top
Published in: Rheumatology International 11/2019

01-11-2019 | ANCA-Associated Vasculitis | Cases with a Message

Cocaine-induced ANCA-associated renal disease: a case-based review

Authors: Fabian Lötscher, Martin Krusche, Nikolas Ruffer, Torsten Kubacki, Fermin Person, Ina Kötter

Published in: Rheumatology International | Issue 11/2019

Login to get access

Abstract

Idiopathic antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are a group of diseases that are often difficult to diagnose due to the wide range of clinical manifestations. Notably, renal involvement is a serious organ complication, which usually requires intensive immunosuppressive therapy and is prone to recurrence. In recent years, there has been some progress regarding the understanding of the pathogenesis of the diseases. It has been shown that both cocaine and levamisole, which is a common adulterant of cocaine, can trigger the formation of ANCAs and lead to the corresponding symptoms. We report two cases of AAV with different renal manifestations associated with cocaine consumption. Furthermore, we performed a review of the literature to identify, characterize and describe histologically documented cases of renal involvement in AAV, related to cocaine abuse. Cocaine/levamisole-induced vasculitis may, therefore, mimic idiopathic AAV. Although the detection of ANCA and anti-PR3 (proteinase 3, PR3) as well as anti-MPO antibodies (myeloperoxidase, MPO) are the serological hallmark of idiopathic AAV, certain clinical- and antibody constellations should lead to consideration of illicit drugs as inductors of the disease. Especially in young patients, certain serologic constellations (e.g., PR3 and MPO double positivity, positive antinuclear antibodies, low complement level, and positive testing for antiphospholipid antibodies), skin involvement, musculoskeletal symptoms and hematologic (anemia, leukopenia) affections should prompt testing for cocaine and levamisole consumption via urine drug testing. Treatment includes both immunosuppressive approaches and drug cessation but is difficult since many patients continue cocaine consumption.
Appendix
Available only for authorised users
Literature
6.
go back to reference Armstrong M Jr, Shikani AH (1996) Nasal septal necrosis mimicking Wegener’s granulomatosis in a cocaine abuser. Ear Nose Throat J 75(9):623–626CrossRef Armstrong M Jr, Shikani AH (1996) Nasal septal necrosis mimicking Wegener’s granulomatosis in a cocaine abuser. Ear Nose Throat J 75(9):623–626CrossRef
9.
go back to reference Centers for Disease C, Prevention (2009) Agranulocytosis associated with cocaine use—four States, March 2008–November 2009. MMWR Morb Mortal Wkly Rep 58(49):1381–1385 Centers for Disease C, Prevention (2009) Agranulocytosis associated with cocaine use—four States, March 2008–November 2009. MMWR Morb Mortal Wkly Rep 58(49):1381–1385
16.
go back to reference Chawdhary K, Parke A (2015) Levamisole-induced vasculitis with renal involvement. Conn Med 79(6):343–346PubMed Chawdhary K, Parke A (2015) Levamisole-induced vasculitis with renal involvement. Conn Med 79(6):343–346PubMed
26.
go back to reference Muñoz-Vahos CH, Herrera-Uribe S, Arbelaez-Cortes A, Jaramillo-Arroyave D, Gonzalez-Naranjo LA, Vasquez-Duque G, Restrepo-Escobar M, Correa-Londono LA, Arias-Restrepo LF, Vanegas-Garcia AL (2019) Clinical profile of levamisole-adulterated cocaine-induced vasculitis/vasculopathy: a 30-case series. J Clin Rheumatol 25(3):e16–e26. https://doi.org/10.1097/RHU.0000000000000813CrossRefPubMed Muñoz-Vahos CH, Herrera-Uribe S, Arbelaez-Cortes A, Jaramillo-Arroyave D, Gonzalez-Naranjo LA, Vasquez-Duque G, Restrepo-Escobar M, Correa-Londono LA, Arias-Restrepo LF, Vanegas-Garcia AL (2019) Clinical profile of levamisole-adulterated cocaine-induced vasculitis/vasculopathy: a 30-case series. J Clin Rheumatol 25(3):e16–e26. https://​doi.​org/​10.​1097/​RHU.​0000000000000813​CrossRefPubMed
38.
go back to reference Jennette JC, Wilkman AS, Falk RJ (1989) Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135(5):921–930PubMedPubMedCentral Jennette JC, Wilkman AS, Falk RJ (1989) Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135(5):921–930PubMedPubMedCentral
48.
go back to reference Preston KL, Epstein DH, Cone EJ, Wtsadik AT, Huestis MA, Moolchan ET (2002) Urinary elimination of cocaine metabolites in chronic cocaine users during cessation. J Anal Toxicol 26(7):393–400CrossRef Preston KL, Epstein DH, Cone EJ, Wtsadik AT, Huestis MA, Moolchan ET (2002) Urinary elimination of cocaine metabolites in chronic cocaine users during cessation. J Anal Toxicol 26(7):393–400CrossRef
49.
go back to reference Lynch KL, Dominy SS, Graf J, Kral AH (2011) Detection of levamisole exposure in cocaine users by liquid chromatography–tandem mass spectrometry. J Anal Toxicol 35(3):176–178CrossRef Lynch KL, Dominy SS, Graf J, Kral AH (2011) Detection of levamisole exposure in cocaine users by liquid chromatography–tandem mass spectrometry. J Anal Toxicol 35(3):176–178CrossRef
Metadata
Title
Cocaine-induced ANCA-associated renal disease: a case-based review
Authors
Fabian Lötscher
Martin Krusche
Nikolas Ruffer
Torsten Kubacki
Fermin Person
Ina Kötter
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 11/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04410-9

Other articles of this Issue 11/2019

Rheumatology International 11/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.